Related Experiment Video
Updated: May 27, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori eradication for Parkinson's disease
Karen Rees1, Rebecca Stowe, Smitaa Patel
11Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK. Karen.Rees@warwick.ac.uk
The Cochrane Database of Systematic Reviews
|November 11, 2011
Summary
Treating Helicobacter pylori (H pylori) infection in Parkinson's disease patients may improve levodopa absorption and motor symptoms. Further research is needed to confirm these findings and establish optimal treatment protocols.
Area of Science:
- Neurology
- Gastroenterology
- Infectious Diseases
Background:
- Parkinson's disease (PD) motor symptoms are primarily managed with levodopa.
- Levodopa absorption variability and 'wearing off' phenomena impact treatment efficacy.
- Helicobacter pylori (H pylori) infection is common and may influence levodopa absorption.
Purpose of the Study:
- Determine H pylori prevalence in Parkinson's disease patients.
- Evaluate the efficacy of H pylori treatment on PD symptoms and levodopa absorption.
Main Methods:
- Systematic literature search of multiple databases and trial registers.
- Inclusion of clinical trials on H pylori-positive PD patients.
- Descriptive analysis of data from selected studies.
Main Results:
- H pylori prevalence in PD ranges from 37% to 59%, similar to the general population.
- One trial indicated H pylori eradication significantly improved levodopa absorption and motor symptoms.
- Worsening of PD symptoms was observed with failed eradication.
Conclusions:
- Limited evidence suggests H pylori eradication may benefit PD patients by improving levodopa absorption and motor function.
- Further high-quality randomized controlled trials are necessary to validate these findings.
- Standardized outcome measures and cost-effectiveness analyses are needed for future research.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...